$86.50 $1.90 (2.2%)

04:00 PM EDT on 09/20/19

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

CAPS Rating: 3 out of 5

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

Current Price $86.50 Mkt Cap $9.1B
Open $84.90 P/E Ratio 0.00
Prev. Close $84.60 Div. (Yield) $0.00 (0.0%)
Daily Range $84.77 - $87.19 Volume 1,276,129
52-Wk Range $65.81 - $96.08 Avg. Daily Vol. 20

Caps

How do you think NASDAQ:ALNY will perform against the market?

Add Stock to CAPS Watchlist

All Players

376 Outperform
39 Underperform
 

All-Star Players

83 Outperform
17 Underperform
 

Wall Street

10 Outperform
3 Underperform
 

Top NASDAQ:ALNY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

neozyklon (62.96)
Submitted January 13, 2017

patisiran..One drug is enough..

PDTBiotech (88.41)
Submitted December 17, 2010

Alnylam has done an amazing job at keeping RNAi hyped as a legitimate technology, but the jig seems to be nearly up. Deal flow has been declining for a few years, marquis partners are starting to throw in the towel, and anyone who has ever worked… More

NASDAQ:ALNY VS S&P 500 (SPY)

Fools bullish on NASDAQ:ALNY are also bullish on:

Fools bearish on NASDAQ:ALNY are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ALNY.

Recs

0
Member Avatar Bigsef77 (67.83) Submitted: 5/8/2018 9:52:02 AM : Outperform Start Price: $119.03 NASDAQ:ALNY Score: -43.91

Alnylam Reports Preclinical Data Demonstrating Central Nervous System (CNS) Delivery of RNAi Therapeutics

Recs

0
Member Avatar TurksFan (43.75) Submitted: 4/7/2018 8:43:26 AM : Outperform Start Price: $96.16 NASDAQ:ALNY Score: -24.19

Starting my research into biotechs

Recs

0
Member Avatar meridius91 (78.85) Submitted: 1/20/2018 7:15:33 PM : Outperform Start Price: $126.07 NASDAQ:ALNY Score: -37.87

Alnylam looks have to the lead in an entirely new form of medicine in RNAi with drug approvals (hopefully) right around the corner. The valuation has shot up in 2017 but this is still a story in the making!

Leaderboard

Find the members with the highest scoring picks in ALNY.

Score Leader

TrackJMP

TrackJMP (84.44) Score: +880.60

The Score Leader is the player with the highest score across all their picks in ALNY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. hayrettin 70.61 12/15/2011 Outperform 5Y $7.76 +1,015.41% +143.70% +871.71 0 Comment
MyunderratedLife 96.38 12/10/2010 Outperform 5Y $8.93 +868.65% +140.58% +728.07 0 Comment
GreyhoundSpirit < 20 6/13/2011 Outperform 5Y $9.02 +858.98% +133.28% +725.70 0 Comment
dbjella < 20 6/29/2011 Outperform 5Y $9.31 +829.11% +129.14% +699.97 0 Comment
embodiedheart < 20 12/9/2010 Outperform 5Y $9.20 +840.22% +140.65% +699.56 0 Comment
isusan < 20 3/23/2011 1/19/2017 Outperform 5Y $9.47 +813.41% +132.15% +681.26 0 Comment
BucephalusGroup < 20 5/5/2011 Outperform 5Y $9.62 +799.17% +122.68% +676.49 0 Comment
GoodSwimmer86 < 20 12/8/2010 Outperform 3Y $9.47 +813.41% +142.97% +670.44 1 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. mechming < 20 11/22/2010 Outperform 5Y $9.50 +810.53% +148.69% +661.84 0 Comment
AllStarPortfolio 22.13 12/27/2010 Outperform 5Y $9.61 +800.10% +138.39% +661.72 2 Comments

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackStifel 91.18 8/8/2018 Outperform NS $93.90 -7.88% +4.54% -12.42 0 Comment
TrackJimCramer 86.27 6/24/2016 Underperform 3W $54.31 +59.27% +46.79% -12.48 0 Comment
TrackDeutscheSec 82.12 5/24/2013 Outperform NS $28.84 +199.93% +81.39% +118.54 0 Comment
TrackPiperJaff 86.21 12/12/2012 Outperform NS $18.48 +170.45% +16.16% +154.29 7/12/2013 @ $49.98 0 Comment
TrackZacks < 20 8/6/2012 Outperform 3M $18.44 -0.38% +2.67% -3.05 9/6/2012 @ $18.37 1 Comment
TrackZacks < 20 6/21/2012 Outperform 3M $11.33 +10.50% +2.50% +8.00 7/13/2012 @ $12.52 1 Comment
TrackPoisedTo < 20 6/13/2012 Underperform 5Y $11.46 +654.80% +125.11% -529.69 0 Comment
TrackJPMorgan 87.17 5/8/2012 Outperform NS $10.20 +747.96% +118.92% +629.04 0 Comment
TrackZacks < 20 2/2/2012 Outperform 3M $12.08 +2.57% +2.18% +0.38 2/13/2012 @ $12.39 1 Comment
TrackJMP 84.44 12/15/2011 Outperform NS $7.69 +1,024.84% +144.24% +880.60 0 Comment
TrackZacks < 20 11/2/2011 Outperform 3M $7.78 +34.96% +6.15% +28.82 1/23/2012 @ $10.50 1 Comment
trackmlvcapital < 20 5/6/2011 Outperform NS $9.66 +795.45% +121.09% +674.35 0 Comment
TrackJimCramer 86.27 1/3/2011 Outperform 3W $8.66 +527.14% +59.41% +467.73 6/24/2016 @ $54.31 0 Comment
trackthinkequity 89.06 5/20/2010 Outperform NS $16.06 +438.61% +172.76% +265.85 0 Comment
TrackJefferies 78.28 6/10/2009 Outperform NS $22.03 +292.65% +215.74% +76.91 0 Comment
TrackRothCapital 59.62 6/10/2009 Outperform NS $22.03 -23.97% +15.76% -39.73 11/24/2009 @ $16.75 0 Comment
TrackLeerinkSwan 96.88 8/20/2008 Underperform NS $31.93 +170.91% +141.68% -29.23 0 Comment
TrackNeedham 90.07 3/3/2008 Underperform NS $26.50 -20.87% -42.14% -21.28 2/25/2009 @ $20.97 0 Comment
TrackCarisandCo 87.11 2/8/2008 Outperform NS $32.94 -22.22% -1.08% -21.14 3/13/2008 @ $25.62 0 Comment
TrackCantorFitz 40.70 9/11/2007 Outperform NS $27.06 +219.66% +114.75% +104.91 0 Comment
TrackCarisandCo 87.11 7/10/2007 Outperform NS $23.01 +38.24% +0.87% +37.37 9/19/2007 @ $31.81 0 Comment
TrackRodmanRen < 20 11/3/2006 Outperform NS $18.45 +368.83% +130.69% +238.15 0 Comment
TrackBofASec 91.57 10/31/2006 Outperform NS $20.71 +317.67% +129.29% +188.38 0 Comment